Bladder cancer Doctors Abroad — Page 3

Associate Professor Dr. Yusuf Acikgoz brings international oncology experience from Ohio State University to Lokman Hekim University Ankara Hospital.

• Specializes in Medical Oncology with a focus on bladder cancer
• Participated in Phase III clinical trials like CheckMate-649 and Fortitude-101
• Certified in Good Clinical Practice and Human Subjects Protection
• Member of American Society of Clinical Oncology (ASCO)

Dr. Elkhan Mammadov is a medical oncologist. He focuses on cancer diagnosis and treatment, including cytotoxic chemotherapy, hormone therapy, targeted therapy (smart drugs), and immunotherapy.

Education: Azerbaijan Medical University, MD (2004–2010). Istanbul University, Istanbul Faculty of Medicine, Internal Medicine training (2014–2019). Istanbul Medipol Mega University Hospital, Medical Oncology subspecialty training (2019–2022).

Experience: 5 years in Internal Medicine. 3 years in Medical Oncology.

Memberships: Turkish Society for Medical Oncology. ESMO (European Society for Medical Oncology). ASCO (American Society of Clinical Oncology).

Prof. Köstler specializes in targeted therapies for bladder cancer, with extensive research in precision oncology at Wiener Privatklinik.

• Over 22 years of experience of experience in medical oncology
• Focuses on biomarker development and immunotherapy
• Associate Professor at the Medical University of Vienna
• Published in leading international oncology journals

Dr. Hughes Hyun specializes in minimally invasive and robotic surgery for bladder cancer at Sourasky Medical Center.

• Board-certified surgeon with extensive experience
• Focuses on advanced robotic techniques
• Practices at one of Israel's leading medical centers

Expert in bladder cancer treatment with a focus on molecular diagnostics and immunotherapy. Phd Viola Fox leads the Clinic for Haematology, Oncology and Palliative Care at BKZ Solingen.

• Specialized in chemotherapy, immunotherapy, and targeted therapies
• Active member of the American Association for Cancer Research
• Qualified specialist in genetics since 2016
• Deputy Chief Physician at Pulmonology Clinic Köln from 2011

Associate Professor Tahsin Ozatli specializes in breast, lung, and gastrointestinal cancers, treating patients at Istinye University Liv Hospital Bahcesehir.

• Trained in internal medicine at Malatya State Hospital
• Worked at Ankara Oncology Clinic with a focus on oncology
• Member of the oncology department at Erzurum Regional Training and Research Hospital
• Associated professor since 2016

Professor Sebastian Keil leads the Clinic for Diagnostic and Interventional Radiology in Solingen, specializing in advanced imaging techniques.

• Graduated with honors from Julius-Maximilians-Universität Würzburg
• Expert in MRI, CT, and ultrasound for complex interventions
• Former leading doctor under renowned Professor Christian K. Kuhl
• Provides full range of interventional radiology services

Specializing in virotherapy – a cutting-edge field in immunology – Dr. Inta Jaunalksne brings 49 years of experience of experience to bladder cancer treatment at Pallas Clinic.

• Head of Clinical Immunology Center at Pauls Stradins Clinical University Hospital
• Graduate of Riga Medical Institute with internship in Internal Medicine
• Focuses on innovative immunological approaches to cancer treatment

Professor Cemil Bilir specializes in bladder cancer with extensive training at prestigious institutions like Cleveland Clinic and Northeastern University.

• Board-certified in medical oncology with over 21 years of experience of experience
• Member of ASCO and ESMO – follows international treatment guidelines
• Conducts research in pharmaceutical biotechnology for advanced therapies
• Professor at Sakarya University – trains future oncologists

Dr. Ozden specializes in bladder cancer treatment with extensive training in medical oncology at Kocaeli University Faculty of Medicine.

• Over 27 years of experience of experience in internal medicine and oncology
• Trained at Istanbul University, one of Turkey's top medical schools
• Expert in chemotherapy and immunotherapy protocols for bladder cancer

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at Liv Hospital Topkapı. He specializes in treating colon, breast, gastric, and lung cancers. He previously served as the Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital. Dr. Atci is a member of the American Society of Clinical Oncology (ASCO).

• Author of 19 peer-reviewed papers on gastrointestinal, thoracic, and endocrine cancers.
• Published studies on survival outcomes for stage IIB colon cancer in the Journal of Chemotherapy.
• Researches prognostic biomarkers using PET/CT scans and metabolic tumor volume.
• Treats complex oncological cases at the university-affiliated İstinye University clinic.

Dr. Mariam Abu Zeid is a clinical oncologist at Shefaa Al Orman International Oncology Hospitals. She is certified by the European Society for Medical Oncology. Dr. Abu Zeid treats solid tumors and hematologic cancers. She holds a Ph.D. in Clinical Oncology and Nuclear Medicine from Ain Shams University.

• Administers chemotherapy, immunotherapy, and targeted treatments for various cancer types.
• Oversees oncology clinical trials and manages treatment-related toxicities.
• Coordinates patient care within multidisciplinary teams for complex staging and diagnosis.
• Practices at an ESMO-accredited center that treats approximately 6,000 patients annually.

Dr. Irfan Cicin is a Professor of Medical Oncology at İstinye University Liv Hospital Topkapı. He specializes in treating complex cancers, including glioblastoma, lung cancer, and pancreatic tumors. He serves as a professor at the Trakya University Faculty of Medicine. Dr. Cicin previously served as a physician in the Turkish Air Force.

• Performs systemic therapies such as immunotherapy, chemotherapy, and hormone therapy.
• Treats a wide range of conditions including gynecologic, orthopedic, and neuro-oncology cases.
• Expert in HIPEC and chemoembolization for liver and abdominal malignancies.
• Works at a 300-bed university hospital with 33 medical departments.

Professor Zheng Qiu Hong is Director of the Cell Therapy Research Center and a National Senior Expert in Biotherapy. He is a Professor and Master’s Supervisor at Fujian Medical University. He has more than 30 years of clinical experience in tumor molecular biology and biotherapy. From 2012 to 2013, he was a visiting scholar in stem cell research at the University of Connecticut School of Life Sciences. He previously held leadership roles at Fujian Cancer Hospital. These roles included Director of the Tumor Molecular Biology Laboratory and Director of the Surgical Oncology Research Laboratory. He also served as Deputy Director of the Fujian Key Laboratory of Tumor Biotherapy and Deputy Director of the Biotherapy and Immunotherapy Center.

Appointments include Standing Committee Member of the Biotherapy Committee of the Chinese Research Hospital Association. He is also a Committee Member of the Tumor Immunology and Biotherapy Committee of the Chinese Society for Immunology. In addition, he is Deputy Chair of the Academic Committee of the Xiamen Cell Therapy Research Center at the First Affiliated Hospital of Xiamen University.

Dr. Liu Shi Xin is the Vice Chairman of the Radiation Oncology Branch of the Chinese Medical Association. He serves as the Discipline Leader of the Oncology Center at Xiamen Humanity Hospital. Dr. Liu specializes in precision radiotherapy for thoracic and abdominal cancers. He is a recipient of the State Council Special Government Allowance for his medical contributions.

• Highly proficient in IMRT, VMAT, and SBRT for lung and esophageal cancers.
• Former President of Jilin Provincial Cancer Hospital.
• Awarded the National Famous Doctor honor for outstanding contributions to oncology.
• Holds leadership roles in the Chinese Anti-Cancer Association particle therapy committee.

Urologist, Surgeon

Dr. Zohar Dotan heads the Urology Department at Sheba Medical Center in Israel. He is a primary pioneer of robotic and laparoscopic urologic surgery. He specializes in treating complex cancers of the kidney, prostate, and bladder. Dr. Dotan leads the Israeli Uro-Oncology Society and holds a PhD in Genetics.

• Completed a specialized uro-oncology fellowship at Memorial Sloan Kettering in New York.
• Performs robotic radical nephrectomy and da Vinci robotic prostatectomy.
• Authored over 50 scientific publications on advanced urologic cancer treatments.
• Works at Sheba Medical Center, ranked 7th best hospital globally by Newsweek.

Dr. Emad Shash is a medical oncologist who has participated in over 70 oncology clinical trials. He serves as the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. Dr. Shash specializes in systemic therapies, including chemotherapy, targeted therapy, and immunotherapy. He holds a Diploma in Hospital Quality Management and Patient Safety from JCI.

• Serves as an ESMO panel voting member and an ASCO committee member.
• Treats breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers.
• Former research physician and medical lead at the EORTC in Brussels.
• Works at Shefaa Al Orman, an ESMO-accredited oncology center treating 6,000 patients annually.

Dr. Amiel is the Head of the Urology Department at Rambam Medical Center, focusing on cancer surgery. His role highlights deep expertise in complex urological cases.

• Specializes as an oncosurgeon for urinary system cancers
• Provides care at a major university hospital in Israel